Back
ProShares Ultra Nasdaq Biotechnology Vs. ProShares Ultra Real Estate Industry Stock Comparison
Buy
55
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
56.64
Seasonality Move:
6.21%
Buy
53
URE
ProShares Ultra Real Estate
Last Price:
54.78
Seasonality Move:
4.06%
Buy
55
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Buy
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $56.67. The Score for BIB is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- BIB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
ProShares Ultra Real Estate (URE)
is a Buy
Is ProShares Ultra Real Estate a Buy, Sell or Hold?
- The current ProShares Ultra Real Estate [URE] share price is $53.71. The Score for URE is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- URE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $56.67
The current trend is moderately bullish and BIB is experiencing selling pressure, which indicates risk of future bearish movement.
URE Stock Price Chart
What is ProShares Ultra Real Estate's stock price today?
-
The ProShares Ultra Real Estate share price today is $53.71
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and URE is experiencing selling pressure, which indicates risk of future bearish movement.
BIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.18 | Buy |
| Relative Strength Index (14 RSI): | 56.18 | Buy |
| Chaikin Money Flow: | -11470 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.34 - 57.4) | Buy |
| Bollinger Bands (100): | (53.08 - 59.32) | Buy |
URE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.33 | Buy |
| Relative Strength Index (14 RSI): | 43.48 | Sell |
| Chaikin Money Flow: | -1789 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.8 - 56.58) | Sell |
| Bollinger Bands (100): | (54.04 - 60.64) | Sell |
BIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.41 | Sell |
| 20-day SMA: | 55.55 | Buy |
| 50-day SMA: | 54.17 | Buy |
| 200-day SMA: | 52.33 | Buy |
| 8-day EMA: | 56.97 | Sell |
| 20-day EMA: | 55.74 | Buy |
| 50-day EMA: | 54.94 | Buy |
| 200-day EMA: | 53.94 | Buy |
URE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.56 | Sell |
| 20-day SMA: | 54.82 | Sell |
| 50-day SMA: | 55.45 | Sell |
| 200-day SMA: | 54.7 | Sell |
| 8-day EMA: | 55.51 | Sell |
| 20-day EMA: | 55.23 | Sell |
| 50-day EMA: | 55.54 | Sell |
| 200-day EMA: | 56.39 | Sell |
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Real Estate Earnings Growth & URE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProShares Ultra Real Estate Technical Analysis
| May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||